Oxurion Launches Exagis eTMF Module to Enhance Clinical Trials

Oxurion, a biopharmaceutical company based in Leuven, Belgium, has introduced its electronic Trial Master File (eTMF) module, a step towards expanding its Exagis eClinical software platform. The new module is designed to improve efficiency, ease clinical trial operations, and ensure regulatory compliance.

Developed by Axiodis CRO, Oxurion's subsidiary, the Exagis platform reflects extensive real-world clinical operations. It caters to the needs of sponsors and research teams by integrating software development with clinical execution.

This launch marks progress in Oxurion's strategy to build a comprehensive eClinical platform. Future updates may include AI-assisted study design, adaptive randomization, and advanced analytics to enhance platform value and customer engagement.